Overcoming Poor Solubility: Advanced Formulation in the Small Molecules Innovator CDMO Market
The golden era of discovering easily soluble, highly bioavailable small molecules is largely over. Today, the global pharmaceutical pipeline is overflowing with highly complex, hydrophobic compounds that present massive formulation challenges. It is estimated that up to 70% to 80% of new active pharmaceutical ingredients (APIs) fall into Biopharmaceutics Classification System (BCS) Class II or...
0 Commenti 0 condivisioni 364 Views 0 Anteprima